Literature DB >> 6468836

Amplification and over-expression of the c-myc gene in Morris hepatomas.

K Hayashi, R Makino, T Sugimura.   

Abstract

Morris hepatoma 7794A was found to have its c-myc gene amplified 5- to 10-fold. The over-expression of c-myc was observed in all three hepatomas studied (Morris hepatomas 5123D, 7136A and 7794A), although in the first two instances the c-myc genes were not amplified. Over-expression or deregulation of c-myc seems to be a general phenomenon associated with hepatoma.

Entities:  

Mesh:

Year:  1984        PMID: 6468836

Source DB:  PubMed          Journal:  Gan        ISSN: 0016-450X


  6 in total

Review 1.  Human cancer and cellular oncogenes.

Authors:  S Nishimura; T Sekiya
Journal:  Biochem J       Date:  1987-04-15       Impact factor: 3.857

2.  Characterization of rat c-myc and adjacent regions.

Authors:  K Hayashi; R Makino; H Kawamura; A Arisawa; K Yoneda
Journal:  Nucleic Acids Res       Date:  1987-08-25       Impact factor: 16.971

3.  Suppression of the protein tyrosine phosphatase receptor type O gene (PTPRO) by methylation in hepatocellular carcinomas.

Authors:  Tasneem Motiwala; Kalpana Ghoshal; Anindita Das; Sarmila Majumder; Dieter Weichenhan; Yue-Zhong Wu; Kristen Holman; S Jill James; Samson T Jacob; Christoph Plass
Journal:  Oncogene       Date:  2003-09-25       Impact factor: 9.867

4.  c-myc gene amplification during hepatocarcinogenesis by a choline-devoid diet.

Authors:  N Chandar; B Lombardi; J Locker
Journal:  Proc Natl Acad Sci U S A       Date:  1989-04       Impact factor: 11.205

5.  Expression of c-fos and c-myc protooncogenes in an immortalized hepatocyte line harbouring SV40 T antigen and hGH as transgenes.

Authors:  K I Hirsch-Ernst; D Paul; G F Kahl; M W Höhne
Journal:  Transgenic Res       Date:  1993-03       Impact factor: 2.788

6.  Expression of oncogenes during rat chemical hepatotumorigenesis promoted by estrogen.

Authors:  Y Himeno; Y Fukuda; M Hatanaka; H Imura
Journal:  Jpn J Cancer Res       Date:  1989-08
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.